Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies — a EuroFlow study
1996 ◽
Vol 95
(2)
◽
pp. 281-290
◽
2020 ◽
Vol 104
(4)
◽
pp. 299-309
◽
2017 ◽
Vol 178
(2)
◽
pp. 257-266
◽
2018 ◽
Vol 71
(7)
◽
pp. 653-658
◽
2001 ◽
Vol 114
(2)
◽
pp. 281-289
◽
2010 ◽
Vol 84
(2)
◽
pp. 117-127
◽